Effect of magnetic resonance imaging in liver metastases

World J Gastroenterol. 2024 Jan 7;30(1):112-114. doi: 10.3748/wjg.v30.i1.112.

Abstract

This letter to the editor is a commentary on a study titled "Liver metastases: The role of magnetic resonance imaging." Exploring a noninvasive imaging evaluation system for the biological behavior of hepatocellular carcinoma (HCC) is the key to achieving precise diagnosis and treatment and improving prognosis. This review summarizes the role of magnetic resonance imaging in the detection and evaluation of liver metastases, describes its main imaging features, and focuses on the added value of the latest imaging tools (such as T1 weighted in phase imaging, T1 weighted out of phase imaging; diffusion-weighted imaging, T2 weighted imaging). In this study, I investigated the necessity and benefits of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid for HCC diagnostic testing and prognostic evaluation.

Keywords: Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid; Hepatobiliary contrast agents; Hepatocellular carcinoma; Liver metastases; Liver-specific contrast agents; Magnetic resonance imaging.

Publication types

  • Review

MeSH terms

  • Carcinoma, Hepatocellular* / pathology
  • Contrast Media
  • Diffusion Magnetic Resonance Imaging
  • Gadolinium DTPA
  • Humans
  • Liver Neoplasms* / pathology
  • Magnetic Resonance Imaging / methods
  • Retrospective Studies

Substances

  • Contrast Media
  • Gadolinium DTPA